Covid-19 and Diabetes Mellitus: A Life-Threatening Reciprocal Association

被引:0
作者
Sharma, Preeti [1 ]
Choudhry, Afreen Arshad [1 ]
Kumar, Pradeep [1 ]
Mahapatra, Tapan [1 ]
机构
[1] Santosh Deemed Univ, Santosh Med Coll, Dept Biochem, Ghaziabad, India
关键词
COVID-19; SARS-Cov-2; Diabetes mellitus; Co morbidities; CVD; RESPIRATORY SYNDROME CORONAVIRUS; CLINICAL CHARACTERISTICS; RISK; INHIBITORS; PNEUMONIA; PLASMA; WUHAN; CARE;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
COVID-19 has taken the world by storm and is now posing as a massive burden on the healthcare services of the world. Another long-standing global epidemic is Diabetes mellitus and Diabetics who get infected with COVID-19 have been seen to have worse outcomes and a high non-survival rate. The global focus is to control the pandemic for which diabetes has proved to be a vulnerable group. The present review aimed to assemble the information about Diabetes mellitus and COVID-19 mainly focusing on the interrelation of pandemics of the past and Diabetes mellitus, possible pathophysiological mechanisms governing COVID-19 in diabetics, the effect of COVID-19 infection on underlying Diabetes mellitus, morbidity, and mortality in diabetic COVID-19 patients and finally the management of Diabetes mellitus in the current pandemic.it is concluded that this COVID-19 pandemic is still lurking and it is of great importance to highlight the fact that a high percentage of the population of the world is affected by various comorbidities like diabetes mellitus, hypertension, COPD, obesity, etc which makes a subset of the population more vulnerable. This vulnerable population is at increased risk for a poor outcome if affected by COVID-19. Hence, we as a society should prioritize this population at risk to avoid adding additional burden to the already overburdened health care system in the present COVID-19 scenario.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 47 条
[1]   Bacterial pneumonia: comparison between diabetics and non-diabetics [J].
Akbar, DH .
ACTA DIABETOLOGICA, 2001, 38 (02) :77-82
[2]   Middle East Respiratory Syndrome Coronavirus: A Case-Control Study of Hospitalized Patients [J].
Al-Tawfiq, Jaffar A. ;
Hinedi, Kareem ;
Ghandour, Jihad ;
Khairalla, Hanan ;
Musleh, Samir ;
Ujayli, Alaa ;
Memish, Ziad A. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (02) :160-165
[3]   Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection [J].
Allard, Robert ;
Leclerc, Pascale ;
Tremblay, Claude ;
Tannenbaum, Terry-Nan .
DIABETES CARE, 2010, 33 (07) :1491-1493
[4]   Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014 [J].
Alraddadi, Basem M. ;
Watson, John T. ;
Almarashi, Abdulatif ;
Abedi, Glen R. ;
Turkistani, Amal ;
Sadran, Musallam ;
Housa, Abeer ;
Almazroa, Mohammad A. ;
Alraihan, Naif ;
Banjar, Ayman ;
Albalawi, Eman ;
Alhindi, Hanan ;
Choudhry, Abdul Jamil ;
Meiman, Jonathan G. ;
Paczkowski, Magdalena ;
Curns, Aaron ;
Mounts, Anthony ;
Feikin, Daniel R. ;
Marano, Nina ;
Swerdlow, David L. ;
Gerber, Susan I. ;
Hajjeh, Rana ;
Madani, Tariq A. .
EMERGING INFECTIOUS DISEASES, 2016, 22 (01) :49-55
[5]   Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis [J].
Badawi, Alaa ;
Ryoo, Seung Gwan .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 49 :129-133
[6]   Diabetes self-management amid COVID-19 pandemic [J].
Banerjee, Mainak ;
Chakraborty, Soumen ;
Pal, Rimesh .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) :351-354
[7]   Covid-19 in Critically Ill Patients in the Seattle Region - Case Series [J].
Bhatraju, Pavan K. ;
Ghassemieh, Bijan J. ;
Nichols, Michelle ;
Kim, Richard ;
Jerome, Keith R. ;
Nalla, Arun K. ;
Greninger, Alexander L. ;
Pipavath, Sudhakar ;
Wurfel, Mark M. ;
Evans, Laura ;
Kritek, Patricia A. ;
West, T. Eoin ;
Luks, Andrew ;
Gerbino, Anthony ;
Dale, Chris R. ;
Goldman, Jason D. ;
O'Mahony, Shane ;
Mikacenic, Carmen .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21) :2012-2022
[8]   Considerations for Obesity, Vitamin D, and Physical Activity Amid the COVID-19 Pandemic [J].
Carter, Stephen J. ;
Baranauskas, Marissa N. ;
Fly, Alyce D. .
OBESITY, 2020, 28 (07) :1176-1177
[9]   Risk of Severe Dysglycemia Among Diabetic Patients Receiving Levofloxacin, Ciprofloxacin, or Moxifloxacin in Taiwan [J].
Chou, Hsu-Wen ;
Wang, Jiun-Ling ;
Chang, Chia-Hsuin ;
Lee, Jen-Jyh ;
Shau, Wen-Yi ;
Lai, Mei-Shu .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (07) :971-980
[10]   Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic [J].
Cure, Erkan ;
Cure, Medine Cumhur .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) :349-350